News

Filter

Current filters:

None

7858 to 7867 of 95894 results

Global osteoporosis market report sees strong showing in China

01-02-2012

The global market for drugs to treat osteoporosis was estimated to be worth $7.3 billion in 2010 and…

AmgenAnti-Arthritics/RheumaticsAsia-PacificGlobalMarkets & MarketingPharmaceuticalXgeva

FDA approves combo diabetes drug Jentadueto and Kalydeco

01-02-2012

The US Food and Drug Administration) has approved Jentadueto (linagliptin/metformin hydrochloride) tablets,…

Boehringer IngelheimDiabetesEli LillyJentaduetoKalydecolinagliptinNorth AmericaPharmaceuticalRare diseasesRegulationVertex

Pfizer’s fourth-quarter net income slumps 50%

01-02-2012

Global drug behemoth Pfizer (NYSE: PFE) reported fourth-quarter 2011 net income of $1.4 billion, a year-on-year…

FinancialPfizerPharmaceutical

Roche posts strong 2011 profits, upbeat on 2012

01-02-2012

Swiss drug major Roche (ROG: SIX) this morning announced that group sales for the full-year 2011 grew…

FinancialPharmaceuticalRoche

Eli Lilly results hammered by Zyprexa patent loss

01-02-2012

US drug major Eli Lilly (NYSE: LLY) said that fourth-quarter 2011 global sales dropped 2% to $6.05 billion.…

Eli LillyFinancialPharmaceutical

Solid 2011 financials from Biogen Idec but forecast disappoints

01-02-2012

US biotech firm Biogen Idec (Nasdaq: BIIB) announced its full year and fourth quarter 2011 results which…

Biogen IdecBiotechnologyFinancial

Two hurdles to jump for SkyePharma, as it changes CEO

31-01-2012

On the same day that UK-based SkyePharma (LSE: SKP) announced that Axel Mueller has resigned as chief…

3MEuropeFinancialFlutiformManagementPharmaceuticalRegulationRespiratory and PulmonarySkyepharma

Allos Thera questions CHMP Folotyn decision; posts new data

31-01-2012

USA-based Allos Therapeutics, Inc. (Nasdaq: ALTH) says that it has submitted a request to the European…

Allos TherapeuticsEuropeFolotynOncologyPharmaceuticalRegulationResearch

Immuron joins academia for C. Difficile therapeutics

31-01-2012

Australian biotechnology firm Immuron (ASX: IMC) has entered into a collaboration agreement with Australia’s…

Antibiotics and Infectious diseasesAsia-PacificBiotechnologyImmuronResearch

7858 to 7867 of 95894 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top